PRISM 3
 

Join the fight
against recurrent
C. difficile

Consider joining the PRISM 3 clinical study

 
Draft3_Stocksy_txpfedd8c01il7200_Large_1964970.png

JOIN THE FIGHT

Patient Fighting Recurrent C. Diff Infections

Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection.

That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.

The investigational treatment, called CP101, is a capsule designed to deliver a full community of beneficial bacteria to the areas of the intestine affected by C. difficile.  The study drug, like fecal microbiota transplantation (FMT), is intended to restore the ecosystem found in a healthy human gut. But unlike traditional fecal transplants, which usually involve colonoscopies or enemas, CP101 is an odorless capsule taken orally. 


Study Features

  • An oral pill designed to repair the microbiome – no bowel prep or colonoscopy required

  • Dedicated, experienced medical care

  • Free transportation and coverage of all study-related costs

Eligibility Criteria

  • 18 years or older

  • Have had a C. diff infection more than once

  • Currently taking antibiotics for a C. diff infection, or will soon start taking antibiotics for a C. diff infection

  • Do not have inflammatory bowel disease (IBD)

-or- use the below map to contact a doctor near you

Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection. That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.

The investigational treatment, called CP101, is a capsule designed to deliver a full community of beneficial bacteria to the areas of the intestine affected by C. difficile. The study drug, like fecal microbiota transplantation (FMT), is intended to restore the ecosystem found in a healthy human gut. But unlike traditional fecal transplants, which usually involve colonoscopies or enemas, CP101 is an odorless capsule taken orally. 


Study Features

  • An oral pill designed to repair the microbiome – no bowel prep or colonoscopy required

  • Dedicated, experienced medical care

  • Free transportation and coverage of all study-related costs

  • Be part of the community working toward a long-term solution to recurrent C. difficile.

Eligibility Criteria

  • 18 years or older

  • Have had a C. diff infection more than once

  • Currently taking antibiotics for a C. diff infection, or will soon start taking antibiotics for a C. diff infection

  • Do not have inflammatory bowel disease (IBD)

-or- use the below map to contact a participating doctor near you